|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
June 10, 2019
Date of Report (Date of Earliest Event Reported)
The Chemours Company
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-36794 |
|
46-4845564 |
|
(State or Other Jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
|
Of Incorporation) |
|
File Number) |
|
Identification No.) |
1007 Market Street
Wilmington, Delaware, 19801
(Address of principal executive offices)
Registrant’s telephone number, including area code: (302) 773-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company |
|
☐ |
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
|
☐ |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of Each Class |
|
Trading Symbol(s) |
|
Name of Exchange on Which Registered |
|
Common Stock ($.01 par value) |
|
CC |
|
New York Stock Exchange |
|
|
|
|
Item 8.01Other Events.
The Chemours Company (“Chemours”) reported today that Mark P. Vergnano, President and Chief Executive Officer, amended his 10b5-1 trading plan (the “Plan”) in order to allow him to purchase shares of Chemours. The Plan, previously reported on a Form 8-K filed with the Securities and Exchange Commission on March 15, 2018, provides for an orderly exercise of stock options prior to their expiration dates.
On June 10, 2019, Mr. Vergnano purchased 44,000 shares of Chemours on the open market at an aggregate cost of approximately $1,019,000. Following this purchase, Mr. Vergnano owns a total of 690,254 shares of Chemours.
Chemours undertakes no obligation to report any other modifications or terminations of the Plan or any other trading plans entered into by Mr. Vergnano or any other officer or director of Chemours, except to the extent required by law.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
THE CHEMOURS COMPANY |
||
|
|
||
|
By: |
|
/s/ Sameer Ralhan |
|
|
|
Sameer Ralhan |
|
|
|
Senior Vice President, Chief Financial |
|
|
|
Officer, and Treasurer |
|
|
||
|
Date: |
|
June 10, 2019 |